A combination of exercise and capsinoid supplementation additively suppresses diet-induced obesity by increasing energy expenditure in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 4, 2015, Pages E315-E323

  Ohyama, Kana ^a,b   Nogusa, Yoshihito ^a   Suzuki, Katsuya ^a   Shinoda, Kosaku ^b   Kajimura, Shingo ^b   Bannai, Makoto ^a  

^a AJINOMOTO CO INC   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Capsinoids; Energy expenditure; Exercise; Fat oxidation; Obesity

Indexed keywords

CAPSAICIN DERIVATIVE; CAPSINOID; CHOLESTEROL; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; INSULIN; LEPTIN; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 1; MYOSIN HEAVY CHAIN BETA; OXYGEN; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; CAPSAICIN; FATTY ACID; HYPOCHOLESTEROLEMIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOCYTE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET SUPPLEMENTATION; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY LIVER; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID STORAGE; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NONSHIVERING THERMOGENESIS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SKELETAL MUSCLE; TREADMILL; TREADMILL EXERCISE; WEIGHT GAIN; WHITE ADIPOCYTE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; BROWN ADIPOSE TISSUE; C57BL MOUSE; COMPARATIVE STUDY; ENERGY METABOLISM; LIPID DIET; METABOLISM; MOTOR ACTIVITY; MULTIMODALITY CANCER THERAPY; OBESITY; PATHOLOGY; RANDOMIZATION; UPREGULATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; ANTICHOLESTEREMIC AGENTS; BEHAVIOR, ANIMAL; CAPSAICIN; COMBINED MODALITY THERAPY; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; LIPOLYSIS; MALE; MICE, INBRED C57BL; MOTOR ACTIVITY; MUSCLE, SKELETAL; OBESITY; OXIDATIVE PHOSPHORYLATION; RANDOM ALLOCATION; UP-REGULATION;

EID: 84922888900     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00354.2014     Document Type: Article

References (61)

1. Anthonsen MW, Ronnstrand L, Wernstedt C, Degerman E, Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 273: 215–221, 1998.
2. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JO. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16: 1879–1886, 2002.
3. Baraldi PG, Preti D, Materazzi S, Geppetti P. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J Med Chem 53: 5085–5107, 2010.
4. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 82: 509–524, 2007.
5. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481: 463–468, 2012.
6. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277–359, 2004.
7. Carlson CL, Winder WW. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. J Appl Physiol 86: 669–674, 1999.
8. Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Mangan-iello VC. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphor-ylation. Proc Natl Acad Sci USA 87: 533–537, 1990.
9. Fedorenko A, Lishko PV, Kirichok Y. Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 151: 400–413, 2012.
10. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497–509, 1957.
11. Haramizu S, Mizunoya W, Masuda Y, Ohnuki K, Watanabe T, Yazawa S, Fushiki T. Capsiate, a nonpungent capsaicin analog, increases endurance swimming capacity of mice by stimulation of vanilloid receptors. Biosci Biotechnol Biochem 70: 774–781, 2006.
12. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31: 1120–1124, 2003.
13. Horowitz JF, Klein S. Lipid metabolism during endurance exercise. Am J Clin Nutr 72: 558S–563S, 2000.
14. Iida T, Moriyama T, Kobata K, Morita A, Murayama N, Hashizume S, Fushiki T, Yazawa S, Watanabe T, Tominaga M. TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology 44: 958–967, 2003.
15. Inoue N, Matsunaga Y, Satoh H, Takahashi M. Enhanced energy expenditure and fat oxidation in humans with high BMI scores by the ingestion of novel and non-pungent capsaicin analogues (capsinoids). Biosci Biotechnol Biochem 71: 380–389, 2007.
16. Jeukendrup AE, Saris WH, Wagenmakers AJ. Fat metabolism during exercise: a review–part II.: regulation of metabolism and the effects of training. Int J Sports Med 19: 293–302, 1998.
17. Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity (Silver Spring) 18: 780–787, 2010.
18. Kawabata F, Inoue N, Yazawa S, Kawada T, Inoue K, Fushiki T. Effects of CH19 sweet, a non-pungent cultivar of red pepper, in decreasing the body weight and suppressing body fat accumulation by sympathetic nerve activation in humans. Biosci Biotechnol Biochem 70: 2824–2835, 2006.
19. Kawada T, Hagihara K, Iwai K. Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr 116: 1272–1278, 1986.
20. Kawai N, Kawai T, Kawai K. Ultrasonic and laboratory studies on fatty liver in white-collar workers. Nihon Shokakibyo Gakkai Zasshi 92: 1058–1065, 1995.
21. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039–E1044, 2000.
22. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 29: 615–623, 2005.
23. Kobata K, Sutoh K, Todo T, Yazawa S, Iwai K, Watanabe T. Nordihydrocapsiate, a new capsinoid from the fruits of a nonpungent pepper, capsicum annuum. J Nat Prod 62: 335–336, 1999.
24. Kobata K, Todo T, Yazawa S, Iwai K, Watanabe T. Novel capsaici-noid-like substances, capsiate and dihydrocapsiate, from the fruits of a nonpungent cultivar, CH-19 Sweet, of Pepper (Capsicum annuum L). J Agric Food Chem 46: 1695–1697, 1998.
25. Kohrt WM, Bloomfield SA, Little KD, Nelson ME, Yingling VR. American College of Sports Medicine Position Stand: physical activity and bone health. Med Sci Sports Exerc 36: 1985–1996, 2004.
26. Lavoie JM, Gauthier MS. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci 63: 1393–1409, 2006.
27. Lee IM. Physical activity, and cancer prevention–data from epidemio-logic studies. Med Sci Sports Exerc 35: 1823–1827, 2003.
28. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797–801, 2002.
29. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 404: 652–660, 2000.
30. Luo Z, Ma L, Zhao Z, He H, Yang D, Feng X, Ma S, Chen X, Zhu T, Cao T, Liu D, Nilius B, Huang Y, Yan Z, Zhu Z. TRPV1 activation improves exercise endurance and energy metabolism through PGC-1alpha upregulation in mice. Cell Res 22: 551–564, 2012.
31. Masuda Y, Haramizu S, Oki K, Ohnuki K, Watanabe T, Yazawa S, Kawada T, Hashizume S, Fushiki T. Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog. J Appl Physiol 95: 2408–2415, 2003.
32. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580: 2917–2921, 2006.
33. Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I. Reduction of diet-induced obesity by a combination of tea-catechin intake and regular swimming. Int J Obes (Lond) 30: 561–568, 2006.
34. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26: 1459–1464, 2002.
35. Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 81: 122–129, 2005.
36. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta 1504: 82–106, 2001.
37. Oh-ishi S, Kizaki T, Toshinai K, Haga S, Fukuda K, Nagata N, Ohno H. Swimming training improves brown-adipose-tissue activity in young and old mice. Mech Ageing Dev 89: 67–78, 1996.
38. Oh KS, Kim EY, Yoon M, Lee CM. Swim training improves leptin receptor deficiency-induced obesity and lipid disorder by activating uncoupling proteins. Exp Mol Med 39: 385–394, 2007.
39. Ohnuki K, Haramizu S, Oki K, Watanabe T, Yazawa S, Fushiki T. Administration of capsiate, a non-pungent capsaicin analog, promotes energy metabolism and suppresses body fat accumulation in mice. Biosci Biotechnol Biochem 65: 2735–2740, 2001.
40. Ohnuki K, Niwa S, Maeda S, Inoue N, Yazawa S, Fushiki T. CH19 sweet, a non-pungent cultivar of red pepper, increased body temperature and oxygen consumption in humans. Biosci Biotechnol Biochem 65: 2033–206, 2001.
41. Ono K, Tsukamoto-Yasui M, Hara-Kimura Y, Inoue N, Nogusa Y, Okabe Y, Nagashima K, Kato F. Intragastric administration of capsiate, a transient receptor potential channel agonist, triggers thermogenic sympathetic responses. J Appl Physiol 110: 789–798, 2011.
42. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB, Saha AK. Coordinate regulation of malonyl-CoA decar-boxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA car-boxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 277: 32571–32577, 2002.
43. Patapoutian A, Peier AM, Story GM, Viswanath V. ThermoTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci 4: 529–539, 2003.
44. Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcrip-tional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546: 851–858, 2003.
45. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78–90, 2003.
46. Sallis JF, Haskell WL, Fortmann SP, Vranizan KM, Taylor CB, Solomon DS. Predictors of adoption and maintenance of physical activity in a community sample. Prev Med 15: 331–341, 1986.
47. Sasahara I, Furuhata Y, Iwasaki Y, Inoue N, Sato H, Watanabe T, Takahashi M. Assessment of the biological similarity of three capsaicin analogs (capsinoids) found in non-pungent chili pepper (CH-19 Sweet) fruits. Biosci Biotechnol Biochem 74: 274–278, 2010.
48. Sherwood NE, Jeffery RW. The behavioral determinants of exercise: implications for physical activity interventions. Annu Rev Nutr 20: 21–44, 2000.
49. Shintaku K, Uchida K, Suzuki Y, Zhou Y, Fushiki T, Watanabe T, Yazawa S, Tominaga M. Activation of transient receptor potential A1 by a non-pungent capsaicin-like compound, capsiate. Br J Pharmacol 165: 1476–1486, 2012.
50. Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr 89: 45–50, 2009.
51. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 104: 531–543, 2001.
52. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, Lindstrom J, Louheranta A. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 7: 147–165, 2004.
53. Tani Y, Fujioka T, Sumioka M, Furuichi Y, Hamada H, Watanabe T. Effects of capsinoid on serum and liver lipids in hyperlipidemic rats. J Nutr Sci Vitaminol (Tokyo) 50: 351–355, 2004.
54. Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta 1801: 299–310, 2010.
55. Urhausen A, Gabriel H, Kindermann W. Blood hormones as markers of training stress and overtraining. Sports Med 20: 251–276, 1995.
56. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1–9, 1949.
57. Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 49: 54–63, 2005.
58. Xu X, Ying Z, Cai M, Xu Z, Li Y, Jiang SY, Tzan K, Wang A, Parthasarathy S, He G, Rajagopalan S, Sun Q. Exercise ameliorates high-fat diet-induced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 300: R1115–R1125, 2011.
59. Yan Z, Okutsu M, Akhtar YN, Lira VA. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol 110: 264–274, 2011.
60. Yoneshiro T, Aita S, Kawai Y, Iwanaga T, Saito M. Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am J Clin Nutr 95: 845–850, 2012.
61. Yoneshiro T, Aita S, Matsushita M, Kayahara T, Kameya T, Kawai Y, Iwanaga T, Saito M. Recruited brown adipose tissue as an antiobesity agent in humans. J Clin Invest 123: 3404–3408, 2013.